Alzheimer's Association
International Conference® 2023 is a wrap - what comes next
depends on you.

Alzheimer's Association

[link removed]

DONATE NOW

[link removed]

AAIC 2023

[link removed]

Dear Friend,

I'm so grateful to the educators,
dementia scientists and advocates who traveled from around the world
to the Alzheimer's Association International Conference® 2023
(AAIC®). They know there's no better place to learn about all the
latest developments in Alzheimer's science, network, share and
collaborate.

I'm also thankful to you. The kind of
progress that was made at AAIC this week doesn't happen without the
generous support of new partners in the fight against Alzheimer's
- like you.

[link removed]

Donate Now

[link removed]

Friend, the
generosity and commitment of friends like you helps make AAIC
possible.

[link removed]

This past week at AAIC was packed
with:

* Advances in Treatments, and Clinical Trial Results: New, more
complete data were reported at AAIC 2023 by Eli Lilly from the
TRAILBLAZER-ALZ 2 Phase 3 clinical trial of donanemab in early
symptomatic Alzheimer's disease. With this fuller picture of the
donanemab Phase 3 results we see additional convincing
scientific evidence that thoroughly removing beta amyloid from
the brain is associated with significant slowing of disease
progression in people living with early Alzheimer's. The results
of this trial also further illustrate that initiating treatment
as early as possible in the course of the disease enables the
possibility of a bigger beneficial effect, but also that there
is potential for slowing of disease progression even when
treatment is started later. The progress we've seen in this
class of treatments, as well as the diversification of potential
new therapies over the past few years, provides hope to those
impacted by this devastating disease.

* Blood Tests: The Next Frontier in Alzheimer's Diagnosis:
Researchers from University of Gothenburg, Sweden, reported
results from a simple, finger prick blood test that shows
promise in the ability to detect markers of Alzheimer's using a
single drop of blood dried on spot cards and shipped overnight
between two countries, without temperature control or cooling.
If validated through additional research, this test could offer
a quick, noninvasive and cost-effective option that is simple
enough to be performed independently, or by caregivers. It may
be particularly valuable for use in rural districts or other
lower resourced areas.

* Volunteering Later in Life May Promote a Healthy Brain: Reported
for the first time at AAIC 2023, researchers from University of
California Davis examined volunteering habits among an ethnic
and racially diverse population of older adults and found that
volunteering was associated with better baseline scores on tests
of memory, thinking and planning. The researchers stated
volunteering may be important for better cognition in late life
and could serve as a simple intervention in older adults to
protect against Alzheimer's and other dementias.

What comes next - more clinical
trials, new approaches to care and support, and increased advocacy to
ensure people living with the early stages of Alzheimer's have access
to new Food and Drug Administration-approved treatments - won't
happen without your support.

We must seize the momentum and do all
we can to accelerate research progress while being there for those
living with Alzheimer's with the care and support that is so needed.
As these researchers return to their labs and offices, their work will
continue, and so will ours, until we achieve our vision of a world
without Alzheimer's and all other dementia.

Will you help us kick off this
exciting new era in the fight to end Alzheimer's with your first gift
now?

[link removed]

Donate Now

[link removed]

I truly believe the sharing and
collaborating that took place this week will lead to more breakthrough
research discoveries. Thank you for supporting our mission to lead the
way to end Alzheimer's and all other dementia - by accelerating
global research, driving risk reduction and early detection, and
maximizing quality care and support.

[link removed]

Gratefully,

Donna McCullough

Chief Mission and Field Operations
Officer

Facebook

[link removed]

Twitter

[link removed]

P.S. While another successful and
energizing AAIC has ended, our work toward a future free from
Alzheimer's and helping improve the lives of those affected by
dementia is ongoing. Please support all our vital work with your first
gift now.

[link removed]

Your donation will strengthen our efforts
to advance Alzheimer's care, support and research. From face-to-face
support to online education programs and promising global research
initiatives, your gift makes a difference in the lives of all those
affected by Alzheimer's and other dementias in your community and
across the world. Thank you for your continued support.

Alzheimer's Association Home Office, 225
N. Michigan Ave., Fl. 17, Chicago, IL 60601

© 2023 Alzheimer's
Association. All rights reserved.
800.272.3900 | alz.org

[link removed]

® | Donate

[link removed]

Please add [email protected] to your address
book to ensure you receive all future emails.

 
Having trouble reading this email?

View it in your browser

[link removed]

 

View your email preferences or
unsubscribe.
[link removed]